Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z

Media Relations
Media Home | Contact Us
US Department of Health and Human Services logo and link

Media Relations Links
• About Us
• Media Contact
• Frequently Asked Questions
• Media Site Map

CDC News
• Press Release Library
• Transcripts
• MMWR Summaries
• B-Roll Footage
• Upcoming Events

Related Links
• Centers at CDC
• Data and Statistics
• Health Topics A-Z
• Image Library
• Publications, Software and Other Products
• Global Health Odyssey
Find your state or local health department
HHS News
National Health Observances
Visit the FirstGov Web Site
Div. of Media Relations
1600 Clifton Road
MS D-14
Atlanta, GA 30333
(404) 639-3286
Fax (404) 639-7394


Telebriefing Transcript
CDC Announces Rubella, Once a Major Cause of Birth Defects, Is No Longer a Health Threat in the U.S.

March 21, 2005

DR. STEVEN COCHI, ACTING DIRECTOR, CDC’S NATIONAL IMMUNIZATION PROGRAM: Good morning. We have two very distinguished guests with us this morning, Dr. Julie Gerberding, the Director of the Centers for Disease Control and Prevention, and Dr. Mirta Roses, who is the Regional Director of the Pan American Health Organization.

We would like to start the program this morning by having Dr. Gerberding tell us about a very special announcement that she would like to make. Dr. Gerberding?

DR. GERBERDING: We are delighted to be here today to formally and officially declare that rubella has been eliminated from the United States. This is a major milestone in the path toward eliminating rubella in other parts of the world, including the Western Hemisphere and other regions that have committed to this very, very important health goal.

But what does it really mean to say we've eliminated rubella? What it means I think is very nicely illustrated on this graphic here. In the 1960s, many, many thousands of children in this country developed rubella. Rubella is the disease that many of us remember as children--the three-day measles or the soft measles, usually not a particularly severe disease for young children, but a devastating disease if women acquire it during pregnancy because it is the cause of the Congenital Rubella Syndrome. That is a very, very serious condition that does result in birth defects, and death, and other complications for unborn children.

So, in the 1960s in this country, we had very large outbreaks of rubella. I was one of those statistics, and I'm sure many people my age or older also remember outbreaks of rubella in their schools. The vaccine was introduced in the late part of the '60s and, for a while, the vaccine was beginning to be used. We were seeing better and better control of rubella. But over time, as you can see in that red line on this graphic, we began to see fewer and fewer cases as immunization rates got higher and higher and higher.

And for the last several years in the United States, we have just had very few cases of rubella, and, recently, the cases that we do have are not cases that are being transmitted in the United States; they are cases that have been imported from other areas of the world where immunization rates are not as high as they are here in the U.S.

So we feel it's very important, after the input of scientists and experts from a variety of reputable and scientific organizations, to make a clear statement that this is an achievement. We owe our success to the wonderful people in the immunization communities across the United States who’ve been working hard to vaccinate children.

But the story is not done yet. There are amazing progress underway in other parts of the Western Hemisphere, which you'll hear about in a minute, but there are still parts of the world where immunization is not common or not common enough to prevent children from developing Congenital Rubella Syndrome. So, in this country, while we can celebrate this milestone, we also have to remain vigilant because, as we say in public health, our network is only as strong as the weakest link. And as long as there is rubella anywhere in the world, there could be rubella in our children, too. So we have to sustain our commitment to immunization. We have to strengthen all of the links in the network, and we have to do everything possible to protect the health of children here within our country, as well as beyond.

Thank you for your interest today in celebrating this occasion. We look forward to further celebrations as more rubella milestones are reached in the future. Thank you.

DR. COCHI: Thank you, Dr. Gerberding.

Now, building on the success in the United States, the Pan American Health Organization has launched a regional initiative, and I would like to call on Dr. Mirta Roses, the Regional Director of the Pan American Health Organization, to say a few words about that initiative.

DR. ROSES PERIAGO: Thank you. Good morning. We are really extremely happy to be here with Julie, as they announce this tremendous success with the rubella elimination and the Congenital Rubella Syndrome elimination. It is always good to have a party and such a kind of party because, in this hemisphere, we have become very used to celebrations like this. Sometimes it starts in one country, sometimes in another, but I think that each country deserves, and the children of each country deserve, to have a huge party when we achieve this kind of success.

As they were mentioning before me, Julie and Steven, I think that we have been partnering with CDC for so many years in order to really ensure that the successes, and the experiences, and the lessons learned and the creativity and innovation in one country serves the rest of the Western Hemisphere at least. And I think that the Region of the Americas is leading in the field of immunization.

In 2003, the Ministers of Health of all the Region of the Americas decided to declare their commitment toward elimination of rubella and Rubella Congenital Syndrome, based on the successes already achieved for measles elimination and, also, as they were saying, some of the countries, together with the U.S., Canada, Panama, Cuba, have already started 30 years ago to immunize their newborns with rubella as the vaccine became available. And so we have cohorts of people that have been protected in these countries, and the possibility of elimination became clearer.

But then more recently, after this decision by all the ministers, and the goal is 2010--so we are going in a good track now with this first country to be declared, right on the goal--I think that we have made a lot of progress, and particularly because most of the countries now in the region have incorporated the vaccine, but many others are, also, catching up in terms of deciding to immunize the adult population so that they will shorten the time that is required to really immunize the people.

And we have had tremendous success for the first time in the challenging activity of reaching to nontraditional groups of people like adults, particularly men and women. Many countries in the region have decided to do immunization weeks, especially to reach adult populations, and many countries have been very innovative in how to solve, how to monitor, how to convince the public about immunization.

And this success that we are having with the rubella is, also, opening a new road and the possibility for improving the access to other adult populations for influenza, eventually for the Papilloma virus vaccine, eventually for the HIV/AIDS vaccine, when they become available.

So we are learning and, at the same time, we are celebrating. The region--Julie mentioned the situation in the U.S.--but the region was having around between 25- and 30,000 cases, and this has dropped dramatically. I'm talking about Congenital Syndrome. And the impact, the economic impact of this, particularly in poor settings, you can imagine what it means to a poor family to have a newborn with disabilities, with very serious defects and how this impairs their progress and the possibility even for the whole family to improve their situations.

So this is, also, a very important, in this case, a very important instrument, also, for poverty reduction in our region--to keep the equity immunization and to prevent families for having more pain and deaths and disabilities that will impair their possibility of success, of development, of improvement of their condition.

We are always, also, having around 100,000 cases of rubella or more, several outbreaks. We are now with almost 99-percent reduction of the cases reported in the region. We have less than 2,000 cases last year, and now we are moving all of us together for another, the third Immunization Week of the Americas that is going to be celebrated in April, end of April this year. The target last year for all the package of immunization was around 45, 46 million people. We are more ambitious this year because all the countries of the Americas are participating, and we hope that the people that are in distant places or that are difficult to reach like people living in border areas or from very vulnerable or poor groups are going to be, also, part of this important immunization week.

And we really thank CDC for having been our partner for more than two decades, in celebrating the achievements of immunization for the region. Thank you.

DR. COCHI: Thank you very much, Dr. Roses.

And now I'd like to open the floor to questions and answers for Dr. Gerberding and Dr. Roses.

Ms. Anita Manning.

QUESTIONER: Is the USA the first country to eliminate rubella anywhere in the world? And then the second--well, actually, can I ask all three of them at once? I wanted to ask about the nine cases in 2004. Can you tell us about those? Were they all in people who had immigrated to this country? And then what year was the vaccine licensed?

DR. GERBERDING: Thank you. The vaccine was licensed in 1969. I just checked that Dr. Cochi to be sure I had that right.

And the cases of rubella that occurred in the past recent timeframes are cases that were acquired in mothers who were infected in their country of origin and brought the virus to the United States or in children born to families from other parts of the world. So, basically, when we say "eliminated," what we really mean is that we are not transmitting the virus from endogenous U.S. cases, but the virus itself has been imported and then caused disease in a vulnerable person--either someone who wasn't vaccinated in their country of origin or, potentially, someone here who missed immunization.

And the first question about the countries. Cuba, actually, eliminated rubella in the 1990s and declared. It probably represents the first country to make that declaration. So the U.S. is not first, but we are still very happy to be where we are today.

QUESTIONER: Thank you. Two questions.

First of all, you touched on this, and I wonder if you might address in more detail the continued need for immunizations. I think many parents may see the headline of this and go, "Oh, great. We no longer need immunizations for this." You addressed that. I wonder if you might touch on that in more detail.

And, secondly, given the fact that we still do have rubella in other countries, what is the possibility that it may, again, reinfect this country in a large manner?

DR. GERBERDING: The goal in the United States, ultimately, is to have all children vaccinated effectively against Rubella and the other vaccine-preventable childhood illnesses because we are at constant risk for reintroduction of the virus from other parts of the world. We cannot afford to relax our emphasis on immunization now. This is exactly the time when we need to strengthen our emphasis on immunization even further.

The MMR vaccine is a wonderful vaccine. It saves lives, but also protects children now and will protect them as they become adults and could be at risk for acquiring rubella in adulthood and then being at especially high risk for causing infection in expectant numbers. So this is a time where we need to do even more to strengthen our immunization, not less.

Are there questions from the phone?

OPERATOR: Thank you. We do have a question from Helen Branswell with the Canadian Press.

QUESTIONER: Hi. Thank you for taking my question. I'm wondering--I'm sorry to ask a basic question--is there any animal reservoir of rubella? The reason I ask is because I am wondering if at some point you could--similar campaigns were successful in other parts of the world in eradicating rubella in humans, would we at some point be able to essentially wipe it off the face of the Earth or would there always be some risk of reintroduction from another source?

DR. GERBERDING: Rubella is a disease of humans, so it is, theoretically, possible that rubella could be eradicated. But right now PAHO, and so for the Western Hemisphere, we have declared the goal of elimination. There are other regions of the world that have declared an elimination goal, but the entire world right now has not yet been able to make that commitment because of competing priorities and resource and distribution problems.

So, in theory, eradication is a possible goal down the road, but right now we're concentrating on elimination because that is feasible, and that's, of course, the first step.


OPERATOR: Thank you. Tom Maugh, with the Los Angeles Times, your line is now open.

QUESTIONER: There are pockets of resistance to MMR because of the controversy about the potential link to autism. Has that been impeding your progress in achieving the elimination?

DR. GERBERDING: I think the concerns about vaccine safety are something that all parents have a vested interest in, clinicians are concerned about that, and, of course, so is CDC and PAHO.

Fortunately, we have been able to increase our vaccine coverage over the last several years, despite some of the concerns that have been expressed, and we just need to emphasize that right now there is no evidence of autism or other harm associated with the MMR vaccine in the area of developmental delays or disabilities. So the evidence indicates that this is a safe and effective vaccine, and we need to emphasize its [audio break].

QUESTIONER: I have got two questions. One is on adult vaccination. Can you go over the issues there, both for the U.S. and for the Americas? And, also, now that rubella, there's been a success with rubella, can you predict what disease would be next?

DR. GERBERDING: With respect to immunization of adults for rubella, women of child-bearing age who do not have a history of immunization or immunity, of course, should be vaccinated against rubella to protect them from even the remote possibility that they would come in contact with someone who was carrying rubella. So, even in the context of a country that has eliminated the endogenous or the transmission within the country, it is still very important that all people, and especially expectant mothers have rubella vaccination.

In terms of what comes next, I think we are still working on what comes next, right now, focusing on achievement of the goals at hand, working toward the global reduction in measles, with the goal of achieving a 50-percent reduction by 2005, which it looks like we're likely to achieve globally, but a long way to go with measles internationally. So there is a lot more work to go, and I'll let Dr. Roses comment on measles and the hemisphere.

DR. ROSES PERIAGO: Well, in the hemisphere, I think that, since 1998, several countries--and 1999, also--several countries introduced adult vaccination because, as I mentioned, this is a strategy that will shorten the time and accelerate the progress.

In the past, when the vaccines were introduced in several countries, like 30 years ago, of course, now we have a cohort of people that have been very well immunized, but that is not the situation in all of the countries of the region. That is why, since 1998, and particularly after the ministers declared the goal for 2010, many countries have started vaccinating adult populations, so that we will go, both ends let's say, and reduce the gap and the possibility of transmission, and also because we don't want to get some of the people in reproductive age, particularly, women in reproductive age, as Julie was mentioning, be the ones that are susceptible for an imported case because then you will increase the risk for those people.

So I think that this has been a very important and innovative measure. And as I was mentioning, we will also have repercussions for the introduction and coverage of other antigens that not all of the countries have the full package as the U.S. has because of competing priorities or resource allocation. And this has built trust in the health sector for reaching adult population with the appropriate vaccine. So I think that that has been a tremendous success, also.

DR. GERBERDING: Let's take another phone question, please.

OPERATOR: Thank you. We have no questions at this time. Again, to ask a question, please press star one.

We do have a question from Angela Stewart from the Star Ledger Newspaper.

QUESTIONER: Dr. Periago, can you be more specific when you're talking about the countries where rubella may still be a problem. Can you give us some idea?

DR. GERBERDING: I'm sorry. We were unable to completely hear your question.

QUESTIONER: Yeah, I wanted Dr. Periago to maybe be more specific with regard to the countries where rubella may still be a problem, where there are still significant outbreaks.

DR. ROSES PERIAGO: Well, we only had like 1,600 cases last year for all the hemisphere, so we have not had any particularly important outbreak, I would say, but rather small clusters of cases in countries where we still have not completely reached the immunization coverage.

The countries in the English-speaking Caribbean are fully involved in the campaign, and three of the Andean countries are now, in 2005 and 2006, going to a joint campaign in order to cover the people. I would say that we have pockets in different countries, but no country, particularly, at this point in time, is outside.

I think that the three countries that are going to be totally on board in 2006, not yet in 2005, is the Hispaniola Island, you know, both Dominican Republic and Haiti, and I think that we are, also, with Guatemala, going to make especially, for these are the three countries that are still--we are all working together in order for them to--to guarantee the resources that they need and the operational strengthening of their health sector to reach all of the people. These are the only three countries still that we are planning to have fully on board by 2006.

DR. GERBERDING: Next question.

QUESTIONER: I have a question. First, being when was the last time the United States saw [audio break] and, also, what year would you suspect that there might be global eradication of rubella?

DR. GERBERDING: I’ll let Dr. Cochi answer the question.

DR. COCHI: As far as the first question is concerned, it really was the year 2000 when we had the last circulation or spread of rubella virus indigenously in the United States. So we have been subject only to importations and very limited spread from the imported cases since the year 2000. Could you repeat the second question? I am sorry.

QUESTIONER: When might we see the global eradication of rubella?

DR. COCHI: I think this may be a long-term goal, but right now the world needs to focus its resources on completing polio eradication and the already existing initiative to reduce measles deaths worldwide by the end of this year, as well as the many other global immunization goals that we have. That can be taken up I think in due time, but we are still a ways away from that.

DR. GERBERDING: Other questions?

QUESTIONER: I just had a question to sort of define what you mean by sustained outbreaks. There are still people in this country who lack immunity sufficient to prevent themselves from being infected with rubella, if a case is introduced. So how do you define a sustained outbreak and when was the last sustained outbreak?

DR. GERBERDING: When we have a case of rubella in this country, the case is investigated, and so an evaluation is done to try to understand what might have been the source of the rubella, is there evidence of transmission to others who are not adequately protected, and is there any evidence that that individual has served as a source of transmission to other people.

So, when we say "sustained transmission," we mean that those investigations have revealed linkages where one person got it, and they were connected with somebody else, who was connected with somebody else, and we can cluster the cases in place and time or by other factors that would be strong evidence that they were linked as a set of transmissions--one person gave it to somebody else who gave it to a third person.

That's what we have not been able to identify since 2000. We have an individual case, but even after intensive assessment, no evidence that that individual has infected anybody else. But you are very right. The fact that we don't have 100-percent protection of our population means that if we had enough introductions or there was clustering of very susceptible people, then we could see sustained transmission again. And one more time, that is why we are putting so much emphasis on trying to sustain the highest possible vaccine coverages. Any other questions from the telephone?

OPERATOR: We have no questions from the phone lines, Doctor.

DR. GERBERDING: Going once, going twice for questions from the room.

[No response.]

DR. GERBERDING: Thank you very much for your interest. We really appreciate it, and congratulations to [audio break].

One question from the phone.

OPERATOR: Thank you. Angela Stewart, with the Star Ledger Newspaper, your line is now open.

QUESTIONER: I just wanted to confirm this. In the U.S. last year, there were nine cases of rubella; is that accurate?

DR. GERBERDING: That is accurate. Thank you, everyone. We appreciate your interest.

[End of Press Briefing.]

Listen to the telebriefing

Media Home | Accessibility | Privacy Policy | Contact Us
CDC Home | Search | Health Topics A-Z

This page last updated March 21, 2005

United States Department of Health and Human Services
Centers for Disease Control and Prevention
Office of Communication
Division of Media Relations